Back to Awarded Treatment Trials
Awarded Trial: 18T-003
Grant ID
18T-003
Illness
Schizophrenia
Primary Drug/Intervention
Cromoglycate
Primary Dosage
41.6 mg per day (5.2 mg per spray, 1 spray each nostril four times per day)
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Enrolling
Investigator
Vishwajit Nimgaonkar
Sample Size
100
Duration of Study Period for Each Subject
70 days
Outcome Measurements
N/A
Results
N/A
Publication
N/A
Link
N/A
PI Name
Vishwajit Nimgaonkar
Degree
N/A
Center
Psychiatry and Human Genetics
Institution
University of Pittsburgh
Address
3811 O'Hara Street
City or Town
Pittsburgh
State or Province
PA
Zip or Postal Code
15213
Country
USA
Email Address
vishwajitNL@upmc.edu